Clinical Trials
22 trialsIP9-ATLAS
Imperial College London
ProScreenMRI
Fondazione del Piemonte per l'Oncologia
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
SMART
Chinese University of Hong Kong
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Prostate Diffusion Imaging With Distortion Correction
Norfolk and Norwich University Hospitals NHS Foundation Trust
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
Wake Forest University Health Sciences
ProstaPilot
Masaryk Memorial Cancer Institute
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
Case Comprehensive Cancer Center
FIMRA-P
Guy's and St Thomas' NHS Foundation Trust
ProSa-I
University of Roma La Sapienza
PSMA PET
University of California, San Francisco
MR
University of California, San Francisco
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
Saskatchewan Health Authority - Regina Area
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Dana-Farber Cancer Institute
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
National Institutes of Health Clinical Center (CC)
ProxiScan
University Health Network, Toronto
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Washington University School of Medicine
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
University of Oulu
FIBROP
Gustave Roussy, Cancer Campus, Grand Paris